Gain Therapeutics Ownership | Who Owns Gain Therapeutics?


OverviewForecastFinancialsChart

Gain Therapeutics Ownership Summary


Gain Therapeutics is owned by 15.88% institutional investors, 3.40% insiders, and 80.72% retail investors. Potomac capital management is the largest institutional shareholder, holding 2.89% of GANX shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.94% of its assets in Gain Therapeutics shares.

GANX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockGain Therapeutics15.88%3.40%80.72%
SectorHealthcare Stocks 232.86%10.65%-143.51%
IndustryBiotech Stocks 382.13%10.41%-292.54%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Potomac capital management1.01M2.89%$3.25B
Jones financial companies lllp676.82K2.23%$1.21M
Dme capital management, lp566.13K1.87%$1.00M
Hohimer wealth management330.00K1.84%$422.40K
Cambridge investment research advisors568.64K1.72%$1.10M
Vanguard group569.90K1.63%$1.84M
Geode capital management397.94K1.14%$1.28M
Gsa capital partners llp312.47K0.95%$606.00K
Vanguard fiduciary trust229.98K0.70%$446.16K
Ubs group220.49K0.67%$427.75K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Potomac capital management1.01M2.61%$3.25B
Hohimer wealth management330.00K0.10%$422.40K
Dme capital management, lp566.13K0.04%$1.00M
Gsa capital partners llp312.47K0.04%$606.00K
Millington financial advisors15.00K0.01%$29.25K
Two sigma securities27.32K0.01%$48.36K
Benedict financial advisors15.50K0.01%$30.07K
Oliver luxxe assets20.25K0.01%$39.28K
Virtu financial54.01K0.01%$96.00K
Xtx topco54.20K0.01%$95.94K

Top Buyers

HolderShares% AssetsChange
Potomac capital management1.01M2.61%1.01M
Hohimer wealth management330.00K0.10%330.00K
Gsa capital partners llp312.47K0.04%292.00K
Vanguard fiduciary trust229.98K0.00%229.98K
Ubs group220.49K0.00%139.37K

Top Sellers

HolderShares% AssetsChange
Timelo investment management---605.29K
Alyeska investment group---450.00K
Raymond james & associates---260.02K
Gotham asset management---245.90K
Cable car capital---145.00K

New Positions

HolderShares% AssetsChangeValue
Potomac capital management1.01M2.61%1.01M$3.25B
Hohimer wealth management330.00K0.10%330.00K$422.40K
Vanguard fiduciary trust229.98K0.00%229.98K$446.16K
Stratos wealth partners131.62K0.00%131.62K$255.34K
Xtx topco54.20K0.01%54.20K$95.94K

Sold Out

HolderChange
Hm payson-1.00K
Fny investment advisers-2.00K
Raymond james financial-2.30K
Bnp paribas arbitrage, snc-2.38K
Citadel advisors-2.50K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202532-17.95%5,557,14228.00%157.76%244.35%3-25.00%
Sep 30, 202519-44.12%2,622,446-26.12%86.32%10-37.50%2-50.00%
Jun 30, 2025362.86%3,787,85934.77%1213.00%17-22.73%5150.00%
Mar 31, 20253529.63%2,384,40620.20%814.87%2116.67%350.00%
Dec 31, 202410-50.00%683,297-59.21%26.46%6-33.33%1-75.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr399.89K0.94%28.74K
Fidelity Extended Market Index223.22K0.52%29.20K
BANOR SICAV Rosemary S EUR Acc120.00K0.31%-1.59K
Extended Equity Market Fund E119.89K0.28%77.97K
Blackrock Extended Mkt Fund CF119.89K0.28%-
Extended Equity Market Fund B119.89K0.28%77.97K
Extended Equity Market Fund K102.08K0.24%-748.00
iShares Micro-Cap ETF96.11K0.23%-
BlackRock Extended Equity Market K36.53K0.14%-16.00
Fidelity Total Market Index57.34K0.13%-

Recent Insider Transactions


DateNameRoleActivityValue
Aug 09, 2024Mack Gene CFO and Interim CEOBuy$14.54K
Aug 09, 2024Islam Khalid Executive ChairmanBuy$49.94K
Jul 01, 2024RICHMAN ERIC I-Buy$14.52K
Jul 01, 2024RICHMAN ERIC I-Buy$6.15K
Mar 28, 2024Riley Jeffrey Scott-Buy$115.77K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q2--
2025 Q1--
2024 Q34-
2024 Q2--

GANX Ownership FAQ


Who Owns Gain Therapeutics?

Gain Therapeutics shareholders are primarily institutional investors at 15.88%, followed by 3.40% insiders and 80.72% retail investors. The average institutional ownership in Gain Therapeutics's industry, Biotech Stocks , is 382.13%, which Gain Therapeutics falls below.

Who owns the most shares of Gain Therapeutics?

Gain Therapeutics’s largest shareholders are Potomac capital management (1.01M shares, 2.89%), Jones financial companies lllp (676.82K shares, 2.23%), and Dme capital management, lp (566.13K shares, 1.87%). Together, they hold 6.98% of Gain Therapeutics’s total shares outstanding.

Does Blackrock own Gain Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Gain Therapeutics.

Who is Gain Therapeutics’s biggest shareholder by percentage of total assets invested?

Potomac capital management is Gain Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.61% of its assets in 1.01M Gain Therapeutics shares, valued at 3.25B$.

Who is the top mutual fund holder of Gain Therapeutics shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Gain Therapeutics shares, with 0.94% of its total shares outstanding invested in 399.89K Gain Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools